Medixall Group Inc
MediXall Group, Inc., together with its subsidiaries, provides health solutions in the United States. The company offers Health Karma platform that provides bundle healthcare and well-being services to individuals, employer groups, organizations, associations, resellers, and third-party administrators. MediXall Group, Inc. was incorporated in 1998 and is based in Leesburg, Florida.
Medixall Group Inc (MDXL) - Net Assets
Latest net assets as of June 2025: $-3.62 Million USD
Based on the latest financial reports, Medixall Group Inc (MDXL) has net assets worth $-3.62 Million USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($219.98K) and total liabilities ($3.84 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-3.62 Million |
| % of Total Assets | -1645.0% |
| Annual Growth Rate | N/A |
| 5-Year Change | -1808.17% |
| 10-Year Change | N/A |
| Growth Volatility | 82.41 |
Medixall Group Inc - Net Assets Trend (2013–2024)
This chart illustrates how Medixall Group Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Medixall Group Inc (2013–2024)
The table below shows the annual net assets of Medixall Group Inc from 2013 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-6.52 Million | -77.78% |
| 2023-12-31 | $-3.67 Million | 0.00% |
| 2022-12-31 | $-3.67 Million | -978.84% |
| 2021-12-31 | $-340.12K | -189.06% |
| 2020-12-31 | $381.90K | -3.99% |
| 2019-12-31 | $397.76K | -26.74% |
| 2018-12-31 | $542.96K | +341.82% |
| 2017-12-31 | $-224.53K | +75.20% |
| 2016-12-31 | $-905.53K | +9.65% |
| 2015-12-31 | $-1.00 Million | +4.01% |
| 2014-12-31 | $-1.04 Million | -155.66% |
| 2013-12-31 | $-408.42K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Medixall Group Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 3415621100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $130.49K | % |
| Other Components | $30.52 Million | % |
| Total Equity | $-6.52 Million | 100.00% |
Medixall Group Inc Competitors by Market Cap
The table below lists competitors of Medixall Group Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
noco-noco Inc. Ordinary Share
NASDAQ:NCNC
|
$41.15K |
|
General Silos & Storage
EGX:GSSC
|
$41.26K |
|
MARKS & SPENCER
MU:MA6
|
$41.33K |
|
MAMATA
NSE:MAMATA
|
$41.35K |
|
Hunter Technology Corp
PINK:HOILF
|
$41.07K |
|
TRUE KOSPI Short Strangle 5% OT
KO:570019
|
$41.07K |
|
BLE Kedros R.E.I.C.
AT:BLEKEDROS
|
$40.98K |
|
Meryllion Resources Corp
PINK:MYRLF
|
$40.89K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Medixall Group Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -3,669,365 to -6,523,556, a change of -2,854,191.
- Net loss of 4,563,406 reduced equity.
- Other comprehensive income increased equity by 265.
- Other factors increased equity by 1,708,950.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-4.56 Million | -69.95% |
| Other Comprehensive Income | $265.00 | +0.0% |
| Other Changes | $1.71 Million | +26.2% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Medixall Group Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-12-31 | $-0.17 | $0.00 | x |
| 2013-12-31 | $-0.18 | $0.00 | x |
| 2014-12-31 | $-0.41 | $0.00 | x |
| 2015-12-31 | $-0.40 | $0.00 | x |
| 2016-12-31 | $-0.35 | $0.00 | x |
| 2017-12-31 | $0.00 | $0.00 | x |
| 2018-12-31 | $0.01 | $0.00 | x |
| 2019-12-31 | $0.01 | $0.00 | x |
| 2020-12-31 | $0.00 | $0.00 | x |
| 2021-12-31 | $0.00 | $0.00 | x |
| 2022-12-31 | $-0.03 | $0.00 | x |
| 2023-12-31 | $-0.03 | $0.00 | x |
| 2024-12-31 | $-0.05 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Medixall Group Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -1474.82%
- • Asset Turnover: 1.54x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-227.91%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | 0.00% | 0.00% | 0.00x | 0.00x | $-107.00K |
| 2013 | 0.00% | -2325.16% | 0.93x | 0.00x | $-947.35K |
| 2014 | 0.00% | 0.00% | 0.00x | 0.00x | $-579.67K |
| 2015 | 0.00% | 0.00% | 0.00x | 0.00x | $-248.39K |
| 2016 | 0.00% | 0.00% | 0.00x | 0.00x | $-566.61K |
| 2017 | 0.00% | -7380.62% | 0.06x | 0.00x | $-1.62 Million |
| 2018 | -549.47% | -160572.07% | 0.00x | 1.34x | $-3.04 Million |
| 2019 | -860.05% | -127409.72% | 0.00x | 2.36x | $-3.46 Million |
| 2020 | -1553.28% | 0.00% | 0.00x | 4.30x | $-5.97 Million |
| 2021 | 0.00% | -40245.78% | 0.01x | 0.00x | $-6.00 Million |
| 2022 | 0.00% | -11524.63% | 0.07x | 0.00x | $-6.46 Million |
| 2023 | 0.00% | -11524.63% | 0.07x | 0.00x | $-6.46 Million |
| 2024 | 0.00% | -1474.82% | 1.54x | 0.00x | $-3.91 Million |
Industry Comparison
This section compares Medixall Group Inc's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $79,108,599
- Average return on equity (ROE) among peers: -247.59%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Medixall Group Inc (MDXL) | $-3.62 Million | 0.00% | N/A | $41.10K |
| Accolade, Inc. (ACCD) | $473.79 Million | -97.02% | 0.91x | $448.32 Million |
| Achiko AG (ACHKF) | $-4.58 Million | 0.00% | 0.00x | $314.42K |
| Ascom Holding AG (ACMLF) | $78.70 Million | 22.11% | 1.51x | $152.13 Million |
| Accelera Innovations Inc (ACNV) | $-462.52K | 0.00% | 0.00x | $5.72K |
| Aclarion Inc (ACON) | $-7.08 Million | 0.00% | 0.00x | $1.89 Million |
| Alternate Health Corp (AHGIF) | $1.07 Million | -2231.82% | 7.94x | $6.50K |
| AI/ML Innovations Inc (AIMLF) | $2.09 Million | -130.52% | 0.72x | $6.84 Million |
| NetraMark Holdings Inc. (AINMF) | $-198.56K | 0.00% | 0.00x | $70.13 Million |
| AMJ Global Technology (AMJT) | $-21.78K | 0.00% | 0.00x | $10.99 Million |
| American Well Corp (AMWL) | $247.79 Million | -38.62% | 0.31x | $78.62 Million |